{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:09:26Z","timestamp":1789027766581,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10552-026-02243-z","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:26:30Z","timestamp":1788348390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rural\u2013urban disparities in prostate-specific antigen testing and shared decision-making in the US"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2222-7283","authenticated-orcid":false,"given":"Neill","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael","family":"Blute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Tumin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Parker","family":"Barnwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"16","key":"2243_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2025.0228","volume":"333","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB (2025) Prostate cancer: a review. JAMA 333(16):1433\u20131446. https:\/\/doi.org\/10.1001\/jama.2025.0228","journal-title":"JAMA"},{"key":"2243_CR2","unstructured":"US Preventive Services Task Force. Prostate Cancer: Screening. US preventive services task force. Updated September 5, 2023. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prostate-cancer-screening. Accessed 10 June 2025"},{"issue":"23","key":"2243_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMe2214658","volume":"387","author":"R Gulati","year":"2022","unstructured":"Gulati R (2022) Reducing prostate cancer overdiagnosis. N Engl J Med 387(23):2187\u20132188. https:\/\/doi.org\/10.1056\/NEJMe2214658","journal-title":"N Engl J Med"},{"issue":"5","key":"2243_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004720.pub4","volume":"5","author":"JV Franco","year":"2026","unstructured":"Franco JV, Hwang EC, Jung JH, Vaimberg O, Ilic D, Cleves A et al (2026) Prostate-specific antigen (PSA) test for prostate cancer screening. Cochrane Database Syst Rev 5(5):CD004720. https:\/\/doi.org\/10.1002\/14651858.CD004720.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2243_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10552-007-9083-8","volume":"19","author":"R Etzioni","year":"2008","unstructured":"Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J et al (2008) Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control 19(2):175\u2013181. https:\/\/doi.org\/10.1007\/s10552-007-9083-8","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2243_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/09691413221119238","volume":"29","author":"SD Jackson","year":"2022","unstructured":"Jackson SD, de la Rue MR, Greenslade TP, John AM, Wahid S, Martin RM et al (2022) Screening asymptomatic men for prostate cancer: a comparison of international guidelines on prostate-specific antigen testing. J Med Screen 29(4):268\u2013271. https:\/\/doi.org\/10.1177\/09691413221119238","journal-title":"J Med Screen"},{"key":"2243_CR7","unstructured":"European Commission. EU Funding & Tenders Portal: PRAISE-U project details. EU Funding & Tenders Portal. Accessed August 18, 2026. https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/projects-details\/43332642\/101101217\/EU4H?order=DESC&pageNumber=1&pageSize=50&sortBy=title&keywords=PRAISE-U&isExactMatch=true&programmePeriod=2021-2027&frameworkProgramme=43332642."},{"issue":"2","key":"2243_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.urolonc.2009.12.019","volume":"30","author":"GE Tasian","year":"2012","unstructured":"Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA et al (2012) Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol 30(2):155\u2013160. https:\/\/doi.org\/10.1016\/j.urolonc.2009.12.019","journal-title":"Urol Oncol"},{"issue":"7","key":"2243_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1158\/1055-9965.EPI-19-1232","volume":"29","author":"AC McDonald","year":"2020","unstructured":"McDonald AC, Wasserman E, Lengerich EJ, Raman JD, Geyer NR, Hohl RJ et al (2020) Prostate cancer incidence and aggressiveness in appalachia versus non-appalachia populations in pennsylvania by urban-rural regions, 2004\u20132014. Cancer Epidemiol Biomarkers Prev 29(7):1365\u20131373. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-1232","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2243_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1200\/OP.23.00547","volume":"20","author":"X Shen","year":"2024","unstructured":"Shen X, Kane K, Katz AJ, Usinger D, Cao Y, Chen RC (2024) Differences in rural versus urban patients with prostate cancer in diagnosis and treatment: an analysis of a population-based cohort. JCO Oncol Pract 20(8):1109\u20131114. https:\/\/doi.org\/10.1200\/OP.23.00547","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"2243_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12875-024-02688-8","volume":"25","author":"FB Denijs","year":"2024","unstructured":"Denijs FB, Van Poppel H, Stenzl A, Villanueva T, Vilaseca JM, Ungan M et al (2024) PSA testing in primary care: is it time to change our practice? BMC Prim Care 25(1):436. https:\/\/doi.org\/10.1186\/s12875-024-02688-8","journal-title":"BMC Prim Care"},{"issue":"7","key":"2243_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/jnci\/djac030","volume":"114","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Landier W, Paskett ED, Peters KB, Merrill JK, Phillips J et al (2022) Rural-urban disparities in cancer outcomes: opportunities for future research. J Natl Cancer Inst 114(7):940\u2013952. https:\/\/doi.org\/10.1093\/jnci\/djac030","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2243_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaoncol.2021.5143","volume":"8","author":"MS Leapman","year":"2022","unstructured":"Leapman MS, Wang R, Park H, Yu JB, Sprenkle PC, Cooperberg MR et al (2022) Changes in prostate-specific antigen testing relative to the revised US preventive services task force recommendation on prostate cancer screening. JAMA Oncol 8(1):41\u201347. https:\/\/doi.org\/10.1001\/jamaoncol.2021.5143","journal-title":"JAMA Oncol"},{"issue":"1","key":"2243_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.euo.2023.07.007","volume":"7","author":"Z Qian","year":"2024","unstructured":"Qian Z, Chen X, Cole AP, Abdollah F, Choueiri TK, Kibel AS et al (2024) Changes in prostate-specific antigen screening after the 2018 United States preventive services task force recommendations and through the COVID-19 pandemic. Eur Urol Oncol 7(1):151\u2013154. https:\/\/doi.org\/10.1016\/j.euo.2023.07.007","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"2243_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41391-020-0227-1","volume":"24","author":"C Jiang","year":"2021","unstructured":"Jiang C, Fedewa SA, Wen Y, Jemal A, Han X (2021) Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline. Prostate Cancer Prostatic Dis 24(1):77\u201380. https:\/\/doi.org\/10.1038\/s41391-020-0227-1","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2243_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00238","volume":"9","author":"P Dasgupta","year":"2019","unstructured":"Dasgupta P, Baade PD, Aitken JF, Ralph N, Chambers SK, Dunn J (2019) Geographical variations in prostate cancer outcomes: a systematic review of international evidence. Front Oncol 9:238. https:\/\/doi.org\/10.3389\/fonc.2019.00238","journal-title":"Front Oncol"},{"issue":"4","key":"2243_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.5534\/wjmh.240110","volume":"43","author":"KM Kim","year":"2025","unstructured":"Kim KM, Kim JH (2025) Individual and socioeconomic affecting factors for prostate cancer screening behavior. World J Mens Health 43(4):734\u2013747. https:\/\/doi.org\/10.5534\/wjmh.240110","journal-title":"World J Mens Health"},{"key":"2243_CR18","unstructured":"National Center for Health Statistics. (2019\u20132023). National Health Interview Survey [Public use data file and documentation]. Centers for Disease Control. https:\/\/www.cdc.gov\/nchs\/nhis\/index.html."},{"key":"2243_CR19","unstructured":"National Center for Health Statitics. National Health Interview Survey, 2023 survey description. 2024. Available from: https:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/Dataset_Documentation\/NHIS\/2023\/srvydesc-508.pdf."},{"issue":"1","key":"2243_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jrh.12127","volume":"32","author":"Z Obertov\u00e1","year":"2016","unstructured":"Obertov\u00e1 Z, Hodgson F, Scott-Jones J, Brown C, Lawrenson R (2016) Rural-urban differences in prostate-specific antigen (PSA) screening and its outcomes in New Zealand. J Rural Health 32(1):56\u201362. https:\/\/doi.org\/10.1111\/jrh.12127","journal-title":"J Rural Health"},{"issue":"3","key":"2243_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/ajr.12504","volume":"27","author":"RJS Calopedos","year":"2019","unstructured":"Calopedos RJS, Bang A, Baade P, Yu XQ, Ruthven S, Patel MI et al (2019) Patterns of prostate-specific antigen testing by remoteness of residence and socio-economic status: an Australian population-based study. Aust J Rural Health 27(3):216\u2013223. https:\/\/doi.org\/10.1111\/ajr.12504","journal-title":"Aust J Rural Health"},{"issue":"3","key":"2243_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3122\/jabfm.2021.03.200505","volume":"34","author":"Z Berkowitz","year":"2021","unstructured":"Berkowitz Z, Zhang X, Richards TB, Sabatino SA, Peipins LA, Smith JL (2021) Multilevel small area estimation of prostate-specific antigen screening test in the United States by age group: 2018 Behavioral Risk Factor Surveillance System. J Am Board Fam Med 34(3):634\u2013647. https:\/\/doi.org\/10.3122\/jabfm.2021.03.200505","journal-title":"J Am Board Fam Med"},{"issue":"5","key":"2243_CR23","doi-asserted-by":"publisher","first-page":"e2211869","DOI":"10.1001\/jamanetworkopen.2022.11869","volume":"5","author":"L Burgess","year":"2022","unstructured":"Burgess L, Aldrighetti CM, Ghosh A, Niemierko A, Chino F, Huynh MJ et al (2022) Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer-specific mortality. JAMA Netw Open 5(5):e2211869. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11869","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2243_CR24","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/iju.70085","volume":"32","author":"T Noro","year":"2025","unstructured":"Noro T, Utsumi T, Ishitsuka N, Suzuki Y, Iijima S, Sugizaki Y et al (2025) Impact of the COVID-19 pandemic on prostate cancer: perturbations in screening and diagnostic patterns. Int J Urol 32(8):990\u2013996. https:\/\/doi.org\/10.1111\/iju.70085","journal-title":"Int J Urol"},{"issue":"6","key":"2243_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1158\/1055-9965.EPI-24-1835","volume":"34","author":"P Bandi","year":"2025","unstructured":"Bandi P, Star J, Mazzitelli N, Nargis N, Islami F, Siegel RL et al (2025) Prevalence and review of major modifiable cancer risk factors, HPV vaccination, and cancer screenings in the United States: 2025 update. Cancer Epidemiol Biomarkers Prev 34(6):836\u2013849. https:\/\/doi.org\/10.1158\/1055-9965.EPI-24-1835","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"36","key":"2243_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","volume":"69","author":"ME Czeisler","year":"2020","unstructured":"Czeisler ME, Marynak K, Clarke KEN, Salah Z, Shakya L, Thierry JM et al (2020) Delay or avoidance of medical care because of COVID-19\u2013related concerns\u2014United States, June 2020. MMWR Morb Mortal Wkly Rep 69(36):1250\u20131257","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2243_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116003","volume":"328","author":"SS Mani","year":"2023","unstructured":"Mani SS, Schut RA (2023) The impact of the COVID-19 pandemic on inequalities in preventive health screenings: trends and implications for U.S. population health. Soc Sci Med 328:116003. https:\/\/doi.org\/10.1016\/j.socscimed.2023.116003","journal-title":"Soc Sci Med"},{"issue":"2","key":"2243_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41391-024-00843-x","volume":"28","author":"N Bhojani","year":"2025","unstructured":"Bhojani N, Miller LE, Zorn KC, Chughtai B, Elterman DS, Bhattacharyya S et al (2025) Prevalence and determinants of shared decision-making for PSA testing in the United States. Prostate Cancer Prostatic Dis 28(2):400\u2013404. https:\/\/doi.org\/10.1038\/s41391-024-00843-x","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"2243_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41585-023-00840-0","volume":"21","author":"KR Pekala","year":"2024","unstructured":"Pekala KR, Shill DK, Austria M, Langford AT, Loeb S, Carlsson SV (2024) Shared decision-making before prostate cancer screening decisions. Nat Rev Urol 21(6):329\u2013338. https:\/\/doi.org\/10.1038\/s41585-023-00840-0","journal-title":"Nat Rev Urol"},{"key":"2243_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102492","volume":"88","author":"B Golijanin","year":"2024","unstructured":"Golijanin B, Bhatt V, Homer A, Malshy K, Ochsner A, Wales R et al (2024) Shared decision-making\" for prostate cancer screening: is it a marker of quality preventative healthcare? Cancer Epidemiol 88:102492. https:\/\/doi.org\/10.1016\/j.canep.2023.102492","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"2243_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3122\/jabfm.2017.03.160359","volume":"30","author":"A Radhakrishnan","year":"2017","unstructured":"Radhakrishnan A, Grande D, Ross M, Mitra N, Bekelman J, Stillson C et al (2017) When primary care providers (PCPs) help patients choose prostate cancer treatment. J Am Board Fam Med 30(3):298\u2013307. https:\/\/doi.org\/10.3122\/jabfm.2017.03.160359","journal-title":"J Am Board Fam Med"},{"issue":"5","key":"2243_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1370\/afm.3011","volume":"1","author":"J Fong","year":"2023","unstructured":"Fong J, Venables M, D\u2019Souza D, Maskerine C (2023) Patient communication preferences for prostate cancer screening discussions: a scoping review. Ann Fam Med 1(5):448\u2013455. https:\/\/doi.org\/10.1370\/afm.3011","journal-title":"Ann Fam Med"},{"issue":"1","key":"2243_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ypmed.2004.024","volume":"39","author":"HI Hall","year":"2004","unstructured":"Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Hughes Sinclair A et al (2004) Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 39(1):27\u201335. https:\/\/doi.org\/10.1016\/j.ypmed.2004.024","journal-title":"Prev Med"},{"issue":"1","key":"2243_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08678-9","volume":"22","author":"R Danek","year":"2022","unstructured":"Danek R, Blackburn J, Greene M, Mazurenko O, Menachemi N (2022) Measuring rurality in health services research: a scoping review. BMC Health Serv Res 22(1):1340. https:\/\/doi.org\/10.1186\/s12913-022-08678-9","journal-title":"BMC Health Serv Res"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02243-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02243-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02243-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:49:07Z","timestamp":1789026547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02243-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02243-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DT discloses salary support from the William T. Grant Foundation, Kate B. Reynolds Charitable Trust Foundation, and Lily Grant Office for research and quality improvement projects unrelated to this work. All other authors have no competing interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a secondary analysis oof publicly available, deidentified data. Therefore, no separate institutional review board approval was necessary.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"155"}}